Dr. Girda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-7258
Education & Training
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Obstetrics and Gynecology, 2010 - 2014
- Stony Brook University Health Sciences Center School of MedicineClass of 2010
- University of California Davis HealthFellowship, Gynecologic Oncology
Certifications & Licensure
- CA State Medical License 2014 - Present
- NJ State Medical License 2017 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Start of enrollment: 2014 Oct 27
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Start of enrollment: 2015 Dec 18
- A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2016 Oct 31
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsA phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.Eduardo Gonzalez-Ochoa, Michael Milosevic, Bradley Corr, James L Abbruzzese, Eugenia Girda
International Journal of Gynecological Cancer. 2023-08-07 - 175 citationsPembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope
The New England Journal of Medicine. 2023-06-08 - 9 citationsEvaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancerAdrian Kohut, Mary Cathryn Earnhardt, Nicholas G. Cuccolo, Chi-Son Kim, Mihae Song
Gynecologic Oncology. 2020-01-01
Press Mentions
- Splash Pharmaceuticals Announces Clinical Trial Presentation at the 2018 American Society of Clinical Oncology Annual MeetingMay 29th, 2018
- Experts Address the Latest on Cervical Cancer TreatmentJanuary 26th, 2024
Professional Memberships
- Socitey of Gynecologic OncologyMember
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: